European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score.
about
My approach to the treatment of sclerodermaFunctional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosisN-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis.Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle studyB cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial.The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic SclerosisPrediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis.The association of low complement with disease activity in systemic sclerosis: a prospective cohort study.Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.Spiritual well-being and coping in scleroderma, lupus erythematosus, and melanoma.Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study.Recent advances in the management of juvenile systemic sclerosis.IL-17, IL-6 and IFN-γ in Systemic Sclerosis Patients.The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic SclerosisSleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life.The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index.Increased Periodontal Attachment Loss in Patients With Systemic Sclerosis.Genome-wide DNA methylation analysis in blood cells from patients with Werner syndromeExercise in systemic sclerosis intensifies systemic inflammation and oxidative stress.Coping strategies for activities of daily living in women whose hands affected by systemic sclerosis.N-acetylcysteine infusion improves hepatic perfusion in the early stages of systemic sclerosis.Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis.Familial autoimmunity and polyautoimmunity in 60 Brazilian Midwest patients with systemic sclerosis.Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?Physical activity in patients with systemic sclerosis.Glucocorticoids in systemic sclerosis: patients' beliefs and treatment adherence.Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case-control study.Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma.Serum Soluble Vascular Cell Adhesion Molecule-1 Overexpression Is a Disease Marker in Patients with First-Time Diagnosed Antinuclear Antibodies: A Prospective, Observational Pilot Study.Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.Relationship between serum leptin level and disease activity in patients with systemic sclerosis.Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression.
P2860
Q24618843-9391335B-E911-47BD-B401-AC299C8AD107Q24814170-D4E671F1-D8A0-4BBB-94C9-17E1DDE9D3BFQ33555008-81062487-3654-4D84-8C2B-BC85FEB2EBA9Q33588875-12BC1E22-3ACB-4206-B92A-51A21B6E092EQ33923359-7D2C77EF-B5CC-44B2-9DCD-7249C098C347Q36758822-08F01DFD-B883-4AEF-9851-E00AF672F895Q37282448-924AAB63-5259-4C86-912E-7F9276D227A0Q37358952-31C0E967-AA2C-4344-A807-E22B40FBEA2AQ38630663-4B71991B-F83A-4B77-B470-5D72D4C83B55Q38845830-F03D01D1-1D80-43AD-B77E-0FB106AC3A8EQ38968206-54279070-A303-460A-88B0-0DACA1D9174BQ38969038-5C998E71-72C5-4E10-86C9-40A174EF64CAQ38995396-F7653927-2FD1-4E1E-9791-AC29227A7BA6Q40002833-D755154E-1E69-4160-9AF9-FA4D2BAE9DD7Q40089620-9DE32E7B-5A16-4363-99F0-FCC9E7D1657CQ40404296-F1BF48E0-1287-49EE-B79E-8D8813BC934AQ40774493-326D7938-5082-47B5-9196-C39026877C6DQ41571756-896D5BEF-6177-4AC7-ADD9-A42126371EA1Q42466834-B9D166D5-E441-4CAA-9D88-5707D8E167BCQ42632828-BE6D4F3E-E751-4EE6-94BD-C2C5E2829229Q43263190-0DA7D26D-BB8D-456D-9F16-6458AB5E1EE2Q44147232-D406E611-B191-4A43-9C3A-864B1E9C6881Q46274957-924A9DFF-EF48-4644-8C83-2416A4F7C24DQ47777296-DDB9CA5F-94B5-4D6A-815E-F0A5B371345AQ47905885-478B47DC-FA3C-42F8-9041-6ADA7D471A3FQ48033104-19284CE0-225F-4D48-8570-770804AEFC16Q48048630-03D9CD43-A603-4AD3-BCA9-F8D4B1F2703AQ48058216-68709494-AC55-46C7-8C07-2A0413AC3F0DQ48085664-AF6AB72F-4183-4F10-AF57-197766186E2EQ48592018-B56DA713-7DB5-4A49-B33D-6E0412F0C1ADQ50329525-608E4952-FF61-43BA-B8EB-7C2451826AC5Q53402736-091A5A86-9AB1-44B7-8C89-DC8D58E98702Q54396103-5F5B6227-35E7-4B9D-B7CD-79002F0C3514Q55261205-228458EC-AEFC-43C4-BDF0-168C80801410
P2860
European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
European Scleroderma Study Gro ...... by modified Rodnan skin score.
@en
European Scleroderma Study Gro ...... by modified Rodnan skin score.
@nl
type
label
European Scleroderma Study Gro ...... by modified Rodnan skin score.
@en
European Scleroderma Study Gro ...... by modified Rodnan skin score.
@nl
prefLabel
European Scleroderma Study Gro ...... by modified Rodnan skin score.
@en
European Scleroderma Study Gro ...... by modified Rodnan skin score.
@nl
P2093
P356
P1476
European Scleroderma Study Gro ...... by modified Rodnan skin score.
@en
P2093
Bencivelli W
D'Angelo S
Della Rossa A
Valentini G
P304
P356
10.1136/ARD.62.9.904
P407
P577
2003-09-01T00:00:00Z